{"data":[{"accessionNo":"0001193125-26-338651","formType":"SCHEDULE 13D/A","amendmentNo":13,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":"45256X103","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-31","reportingPerson":"Patrick Soon-Shiong","reportingCik":null,"personType":"IN","sharesOwned":745518285,"percentOfClass":64.8,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-26-338651","formType":"SCHEDULE 13D/A","amendmentNo":13,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":"45256X103","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-31","reportingPerson":"Nant Capital, LLC","reportingCik":null,"personType":"OO","sharesOwned":339465528,"percentOfClass":29.6,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-26-338651","formType":"SCHEDULE 13D/A","amendmentNo":13,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":"45256X103","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-31","reportingPerson":"Cambridge Equities, LP","reportingCik":"0001629222","personType":"PN","sharesOwned":261705814,"percentOfClass":24.7,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-26-338651","formType":"SCHEDULE 13D/A","amendmentNo":13,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":"45256X103","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-31","reportingPerson":"MP 13 Ventures, LLC","reportingCik":null,"personType":"OO","sharesOwned":261705814,"percentOfClass":24.7,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-26-338651","formType":"SCHEDULE 13D/A","amendmentNo":13,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":"45256X103","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-31","reportingPerson":"California Capital Equity, LLC","reportingCik":null,"personType":"OO","sharesOwned":106511412,"percentOfClass":10,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-26-338651","formType":"SCHEDULE 13D/A","amendmentNo":13,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":"45256X103","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-31","reportingPerson":"NantWorks, LLC","reportingCik":null,"personType":"OO","sharesOwned":98535253,"percentOfClass":9.3,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-26-072879","formType":"SCHEDULE 13D/A","amendmentNo":12,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-23","reportingPerson":"Patrick Soon-Shiong","reportingCik":"0001189020","personType":"IN","sharesOwned":745576456,"percentOfClass":66.3,"filedAt":"2026-02-25","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-26-072879","formType":"SCHEDULE 13D/A","amendmentNo":12,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-23","reportingPerson":"Nant Capital, LLC","reportingCik":"0001675758","personType":"OO","sharesOwned":339465529,"percentOfClass":30.3,"filedAt":"2026-02-25","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-26-072879","formType":"SCHEDULE 13D/A","amendmentNo":12,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-23","reportingPerson":"MP 13 Ventures, LLC","reportingCik":"0001629186","personType":"OO","sharesOwned":261705814,"percentOfClass":25.5,"filedAt":"2026-02-25","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-26-072879","formType":"SCHEDULE 13D/A","amendmentNo":12,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-23","reportingPerson":"Cambridge Equities, LP","reportingCik":"0001629222","personType":"PN","sharesOwned":261705814,"percentOfClass":25.5,"filedAt":"2026-02-25","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-26-072879","formType":"SCHEDULE 13D/A","amendmentNo":12,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-23","reportingPerson":"California Capital Equity, LLC","reportingCik":"0001517764","personType":"OO","sharesOwned":106511412,"percentOfClass":10.4,"filedAt":"2026-02-25","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-26-072879","formType":"SCHEDULE 13D/A","amendmentNo":12,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-23","reportingPerson":"NantWorks, LLC","reportingCik":"0001675760","personType":"OO","sharesOwned":98535253,"percentOfClass":9.6,"filedAt":"2026-02-25","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-25-274843","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-10","reportingPerson":"Patrick Soon-Shiong","reportingCik":"0001189020","personType":"IN","sharesOwned":743971200,"percentOfClass":68.9,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-25-274843","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-10","reportingPerson":"Nant Capital, LLC","reportingCik":"0001675758","personType":"OO","sharesOwned":339464529,"percentOfClass":31.5,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-25-274843","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-10","reportingPerson":"MP 13 Ventures, LLC","reportingCik":"0001629186","personType":"OO","sharesOwned":261705814,"percentOfClass":26.6,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-25-274843","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-10","reportingPerson":"Cambridge Equities, LP","reportingCik":"0001629222","personType":"PN","sharesOwned":261705814,"percentOfClass":26.6,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-25-274843","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-10","reportingPerson":"California Capital Equity, LLC","reportingCik":"0001517764","personType":"OO","sharesOwned":106511412,"percentOfClass":10.8,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-25-274843","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-10","reportingPerson":"NantWorks, LLC","reportingCik":"0001675760","personType":"OO","sharesOwned":98535253,"percentOfClass":10,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"},{"accessionNo":"0001193125-25-274843","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001326110","issuerName":"ImmunityBio, Inc.","ticker":"IBRX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-10","reportingPerson":"NantMobile, LLC","reportingCik":"0001567221","personType":"OO","sharesOwned":47557934,"percentOfClass":4.8,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx"}],"updatedAt":"2026-10-29T04:25:09.849Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ibrx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}